The CBD Regulatory Landscape Is Shifting Fast
Federal policy, state laws, and FDA oversight are all in flux. Here's what the current landscape looks like — and where it's headed.
The 2018 Farm Bill legalized hemp-derived CBD at the federal level. But seven years later, the FDA still hasn't established a regulatory framework for CBD in food, beverages, or dietary supplements. This gap has created a $6+ billion market operating in a regulatory gray zone — where products are widely sold but quality standards are voluntary.
The result: enormous variation in product quality, inconsistent state laws, and a constantly evolving policy landscape. Custom CBD Labs tracks these changes — federal proposals, state-level regulations, enforcement actions, and the industry's push for clear rules.
Policy & Regulation
The current federal CBD regulatory landscape: what the 2018 Farm Bill actually says, the FDA's inaction on CBD supplements, and the proposals being considered in Congress.
Continue reading →CBD legality varies by state: some allow full access, others restrict THC content, product types, or sales channels. A state-by-state overview of the current landscape.
Continue reading →Answers to common questions about CBD regulation: is it legal, what testing is required, why the FDA hasn't acted, and what's likely to change.
Continue reading →Populum — Ahead of Regulation
Populum already meets the standards that future CBD regulation will likely require: batch-specific third-party COAs, CO2 extraction, accurate labeling, and cGMP manufacturing. When regulation arrives, they won't need to change anything.
See their lab results at Populum.com →